CardioGenics Holdings Inc
CardioGenics Holdings Inc. engages in the development and commercialization of diagnostic test products for the in vitro diagnostics testing market. Its products include QL Care Analyzer, which is a portable, stand-alone, and automated POC immunoanalyzer; a series of immunoassay tests to enhance the management of patients with cardiovascular diseases; and paramagnetic beads that are used as a sol… Read more
Market Cap & Net Worth: CardioGenics Holdings Inc (CGNH)
CardioGenics Holdings Inc (PINK:CGNH) has a market capitalization of $9.61K ($9.61K) as of March 18, 2026. Listed on the PINK stock exchange, this USA-based company holds position #45049 globally and #14202 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CardioGenics Holdings Inc's stock price $0.00 by its total outstanding shares 96050558 (96.05 Million).
CardioGenics Holdings Inc Market Cap History: 2015 to 2025
CardioGenics Holdings Inc's market capitalization history from 2015 to 2025. Data shows change from $2.16 Million to $9.61K (-45.25% CAGR).
CardioGenics Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CardioGenics Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of CGNH by Market Capitalization
Companies near CardioGenics Holdings Inc in the global market cap rankings as of March 18, 2026.
Key companies related to CardioGenics Holdings Inc by market ranking:
- Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #90 globally with a market cap of $177.20 Billion USD.
- Danaher Corporation (NYSE:DHR): Ranked #151 globally with a market cap of $122.79 Billion USD.
- IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #466 globally with a market cap of $46.38 Billion USD.
- Lonza Group Ltd (PINK:LZAGF): Ranked #511 globally with a market cap of $41.73 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #90 | Thermo Fisher Scientific Inc | NYSE:TMO | $177.20 Billion | $472.71 |
| #151 | Danaher Corporation | NYSE:DHR | $122.79 Billion | $195.21 |
| #466 | IDEXX Laboratories Inc | NASDAQ:IDXX | $46.38 Billion | $586.98 |
| #511 | Lonza Group Ltd | PINK:LZAGF | $41.73 Billion | $596.13 |
CardioGenics Holdings Inc Historical Marketcap From 2015 to 2025
Between 2015 and today, CardioGenics Holdings Inc's market cap moved from $2.16 Million to $ 9.61K, with a yearly change of -45.25%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | $9.61K | 0.00% |
| 2024 | $9.61K | 0.00% |
| 2023 | $9.61K | -50.00% |
| 2022 | $19.21K | +100.00% |
| 2021 | $9.61K | -99.43% |
| 2020 | $1.68 Million | +98.86% |
| 2019 | $845.24K | -64.66% |
| 2018 | $2.39 Million | -11.07% |
| 2017 | $2.69 Million | +214.61% |
| 2016 | $854.85K | -60.44% |
| 2015 | $2.16 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of CardioGenics Holdings Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $9.61K USD |
| MoneyControl | $9.61K USD |
| MarketWatch | $9.61K USD |
| marketcap.company | $9.61K USD |
| Reuters | $9.61K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.